Skip to main content
Erschienen in: BMC Infectious Diseases 1/2024

Open Access 01.12.2024 | Case Report

A case of bacteremia caused by Dialister micraerophilus with Enterocloster clostridioformis and Eggerthella lenta in a patient with pyometra

verfasst von: Hiroki Kitagawa, Kayoko Tadera, Keitaro Omori, Toshihito Nomura, Norifumi Shigemoto, Hiroki Ohge

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2024

Abstract

Background

Infection by Dialister micraerophilus, an obligate anaerobic gram-negative bacillus, has rarely been described, and its clinical characteristics remain unclear.

Case presentation

We report a case of bacteremia caused by D. micraerophilus, Enterocloster clostridioformis, and Eggerthella lenta in a 47-year-old woman, associated with pyometra. D. micraerophilus was identified using 16S rRNA gene sequencing and matrix-assisted laser desorption ionization time-of-flight mass spectrometry. D. micraerophilus was detected by polymerase chain reaction using D. micraerophilus-specific primers and E. clostridioformis and E. lenta was isolated from the drainage pus sample obtained from the pyometra uterus. The patient achieved a cure after abscess drainage and 2-week antibiotic treatment.

Conclusions

To the best of our knowledge, this is the first report of D. micraerophilus bacteremia. D. micraerophilus may be associated with gynecological infections. Clinicians should consider both oral and gynecological sites when searching to identify the focus of D. micraerophilus infection.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

Dialister species are non-fermentative, obligate anaerobic, gram-negative bacillus that are frequently isolated from human clinical samples [1]. Among Dialister spp., D. pneumosintes is a commensal oral microbe [2], which is mainly associated with oral infections such as gingivitis [3], periodontitis [4], and periapical abscess [5]. D. pneumosintes can also cause extra-oral infections such as pneumonia [6], neck and mediastinal abscess [7], sinusitis [8], hepatic abscess [9], and vaginosis [10].
In contrast, Dialister micraerophilus, first described in 2005 [11], has been isolated from cutaneous and soft tissue, gynecological, bone, and oral samples [1, 12, 13]. In addition, D. micraaerophilus was recently detected from vaginal samples [14, 15]. However, only one infection, a Bartholin’s abscess, has been reported previously as due to D. microaerophilus [16].
Herein, we report a case of bacteremia caused by D. micraerophilus, Enterocloster clostridioformis, and Eggerthella lenta associated with pyometra.

Case presentation

A 47-year-old Japanese woman was referred to our hospital for suspected endometrial pyometra. This patient, with a medical history of caesarean section 20 years ago, had a 7-day history of genital bleeding and 3-day history of a fever over 38 °C. The initial evaluation at our hospital revealed a body temperature of 38.2 ℃ and no other symptoms suggestive of sepsis, while physical examination revealed lower abdominal pain. The laboratory results were as follows: white blood cell count of 8,670/µL (neutrophils, 88.6%) and C-reactive protein level of 6.02 mg/dL. Transvaginal echocardiography showed an enlarged uterus with accumulation of fluid in the uterine cavity, suggesting pyometra. Drainage of the uterine cavity was performed and purulent fluid was collected, which were submitted for culture. Two sets of blood cultures were also submitted upon admission, and cefmetazole treatment (1 g every 8 h) was empirically started.
Gram-staining of the pus sample showed a polymicrobial pattern. The pus sample was cultured as previously described [17]. Anaerobic conditions were established using an AnaeroPack System anaerobic jar (Mitsubishi Gas Chemical Co., Inc., Tokyo, Japan) equipped with an AnaeroPack (Mitsubishi Gas Chemical Co., Inc.). Streptococcus gallolyticus subsp. gallolyticus, Peptostreptococcus anaerobius, Aerococcus murdochii, Peptoniphilus lacrimalis, E. clostridioformis (formerly known as Clostridium clostridioforme), and E. lenta, were identified in the pus sample.
Two anaerobic bottles of two sets of blood cultures were evaluated using the BACT/ALERT® VIRTUO® (bioMérieux, Inc., Marcy l’Étoile, France) blood culture detection system with BACT/ALERT® FA Plus and FN Plus bottles (bioMérieux, Inc.), which turned positive after 24 h 36 min and 37 h 54 min (Fig. 1). The two anerobic bottles were subcultured, as well as the pus sample, as previously described. The isolates were identified by using matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) as previously described [17]. On the third day of incubation, tiny colonies of small gram-negative bacillus were observed on Brucella blood agar supplemented with hemin and vitamin K1 plates cultured under anaerobic conditions. D. micraerophilus was identified based on a score of 2.13 from one anaerobic bottle with an incubation period of 24 h 36 min. From the other anaerobic bottle with an incubation period of 37 h 54 min, E. clostridioformis and E. lenta were isolated and identified based on a high score ≥ 2.00. The subculture plates were incubated until day 5; however, no other species grew. Then, 16S rRNA gene sequencing was performed to identify D. micraerophilus isolates, as previously described [17]. This strain showed 100% (1440/1440 bp) similarity to D. micraerophilus DSM 19965 (accession number: AF473837). In addition, DNA was extracted from the pus sample using a MORA-EXTRACT DNA extraction kit (Kyokuto Pharmaceutical Industrial Co., Ltd., Tokyo, Japan). D. micraerophilus was detected in the pus sample by polymerase chain reaction (PCR) using D. micraerophilus-specific primers, dial micra_72F (5’-GGACATGAAAAGCTTGCTTT-3’) and dial micra_222R (5’-AGCGATAGCTTCTTCGATA-3’), and PCR conditions (20 s annealing at 57 ℃ and 20 s extension at 72 ℃) as previously described [14].
The minimum inhibitory concentrations (MICs) of various antimicrobial agents were determined via the broth microdilution method using IA40 MIC-i with Dry Plates Eiken (Eiken Chemical Co., Ltd, Tokyo, Japan) based on the Clinical and Laboratory Standards Institute (CLSI) standards [18]. The MICs were recorded after 48 h of incubation under anaerobic conditions as previously described at 35 ℃ (Table 1).
Table 1
MICs of the Dialister micraerophilus isolate
Antimicrobial agent
MIC (µg/mL)
Penicillin
≤ 0.06
Ampicillin
≤ 0.5
Ampicillin-sulbactam
≤ 0.5
Piperacillin-tazobactam
≤ 2
Ceftriaxone
≤ 1
Cefmetazole
≤ 1
Imipenem
≤ 0.25
Meropenem
≤ 0.25
Moxifloxacin
4
Clindamycin
1
Metronidazole
16
MIC, minimum inhibitory concentration
After diagnosing the patient with D. micraerophilus bacteremia, an intra-oral examination by a dentist revealed no sign of periodontal diseases or abscess. The infection resolved after drainage and empirical 7-day antimicrobial therapy with cefmetazole, followed by another 7-day oral amoxicillin-clavulanate treatment. The patient was discharged from the hospital on day 10. At the 1-week outpatient follow-up, the patient was well and without any complications.

Discussion and conclusions

D. micraerophilus infection has rarely been described, and its clinical characteristics remain unclear. In this case, we diagnosed the patient with bacteremia caused by D. micraerophilus, E. clostridioformis, and E. lenta, associated with pyometra. A previous case report described a Bartholin’s abscess caused by D. micraerophilus [16]. In addition, D. micraerophilus, among Dialister spp., is mainly isolated from gynecological tract samples [1], although has been detected in vaginal samples [14, 15]. Therefore, D. micraerophilus may be associated with gynecological infections. No reported cases of bacteremia caused by D. micraerophilus exist in the available literature of case reports on bacteremia caused by Dialister spp. (Table 2), [58, 10, 19, 20, 21]. Although bacteremia caused by D. pneumosintes is mainly associated with dental infections or sinusitis [58, 19, 20, 21], a case of D. pneumosintes bacteremia associated with vaginosis has been reported [10], and D. pneumosintes has also been isolated from gynecological samples [1].
Table 2
Literature review on Dialister spp. bacteremia cases
No.
Reported year
Age (years)
Sex
No. of positive blood culture bottles for Dialister spp.
Isolated Dialister spp.
Identification method
Polymicrobial bacteremia (isolated organisms other than Dialister spp.)
Time-to-positivity of blood culture of Dialister spp.
Diagnosis (source of bacteremia)
Complicated with infections of oral cavity
Complicated with sinusitis
Antimicrobial treatment
Outcome
Reference
1
2002
17
M
One anaerobic bottle from two blood culture sets
Dialister pneumosintes
16 S rRNA gene sequence analysis
No
3 days (No detailed time was described)
Subdural empyema
No
Yes
Cefotaxime and metronidazole → oral amoxicillin and ofloxacin
Cured
[19]
2
2006
27
F
Unknown number of anaerobic bottles from three blood culture sets
Dialister pneumosintes
16 S rRNA gene sequence analysis
No
No detailed time was described
Postpartum vaginosis and pyogenic thrombosis of the ovarian veins
Not described
Not described
Imipinem and rifampicin
Cured
[10]
3
2015
62
F
Two anaerobic bottles from two blood culture sets
Dialister pneumosintes
16 S rRNA gene sequence analysis
No
36 and 41 h
Dental caries and sinusitis
Yes
Yes
Oral amoxicillin-clavulanate and ciprofloxacin → cefepime → cefepime and levofloxacin → levofloxacin
Cured
[8]
4
2016
78
F
One anaerobic bottle from two blood culture sets
Dialister pneumosintes
16 S rRNA gene sequence analysis
Yes (Slackia exigua)
30 h
Periapical abscess
Yes
Not described
Ceftriaxone and clindamycin
Cured
[5]
5
2021
13
F
One anaerobic bottle from unknown number of blood culture sets
Dialister pneumosintes
MALDI-TOF MS
No
34 h
Pneumonia
No
Yes
Ceftriaxon → piperacillin/tazobactam → meropenem → oral ciprofloxacin and sultamicillin
Cured
[6]
6
2021
30
F
One anaerobic bottle from unknown number of blood culture sets
Dialister pneumosintes
16 S rRNA gene sequence analysis
No
Detailed time not described
Neck and mediastinal abscess
Yes
Not described
Piperacillin/tazobactam → piperacillin/tazobactam and metronidazole → meropenem, vancomycin and oral fluconazole → oral amoxicillin/clavulanic acid and metronidazole
Cured
[7]
7
2022
73
F
Not described
Dialister pneumosintes
16 S rRNA gene sequence analysis
No
2 days (No detailed time was described)
Peritonsillar and retropharyngeal abscess
Yes
Not described
Ampicillin/sulbactam→ ampicillin/sulbactamand metronidazole → oral fluoroquinolone
Cured
[20]
8
2023
75
M
One anaerobic bottle from five blood culture sets
Dialister pneumosintes
MALDI-TOF MS
No
37 h
Aortic graft infection
No
Not described
Piperacillin/tazobactam and vancomycin→benzylpenicillin and gentamicin→oral amoxicillin/clavulanic acid
Cured
[21]
8
Present case
47
F
One anaerobic bottle from two blood culture sets
Dialister micraerophilus
16 S rRNA gene sequence analysis, MALDI-TOF MS
Yes (Enterocloster clostridioformis and Eggerthella lenta)
24 h 36 min
Pyometra
No
Not evaluated
Cefmetazole → oral amoxicillin/clavulanic acid
Cured
 
F, female; M, male; MALDI-TOF MS, matrix-assisted laser desorption ionization time-of-flight mass spectrometry
In the present case, D. micraerophilus was not cultured from the drainage pus sample obtained from the pyometra uterus; this may have been due to the slow growth and tiny colonies of D. micraerophilus. However, D. miraerophilus was detected in the drainage pus sample by PCR using a specific primer. The patient had no other focus of bacteremia, including intra-oral infection, besides pyometra. Cases of bacteremia caused by E. clostridioformis or E. lenta in a patient with pyometra have been reported [22, 23].
In the present case, three anaerobes were isolated from blood cultures. Polymicrobial bacteremia caused by only obligate anaerobes is rare. The frequency of polymicrobial bacteremia cases implicating obligate anaerobes was reportedly 12.9–42.8% in cases of bacteremia implicating anaerobic bacteria (BIAB) [24, 25]. Dumont et al. reported that among 2,465 episodes of bacteremia including 144 BIAB episodes, polymicrobial bacteremia accounted for 301 episodes (12.2%), including 46 episodes involving at least one anaerobe (31.5% of all BIAB episodes) and 13 episodes involving only anaerobes (9.0% of all BIAB episodes) [24]. Watanabe et al. also reported that 42.8% (92/215 cases) of BIAB cases involved polymicrobial bacteremia, and 14.4% (31/215 cases) of BIAB cases were caused by multiple anaerobic bacteria [25]. In addition, Ransom and Burnham reported that among 158,710 blood culture bottles, 6,652 were positive anaerobic bottles, of which 384 (5.8%) contained 403 obligate anaerobes [26]. Moreover, 20.7% (81/392) of BIAB cases were polymicrobial cultures, including 73 cases with two species, 15 cases with three species, and 3 cases with more than three species. However, the frequency of polymicrobial bacteremia caused by only anaerobes was not described. In this study, blood cultures were performed using the BACT/ALERT® VIRTUO® system with BACT/ALERT® FA Plus and FN Plus bottles, similar to our study. Although polymicrobial bacteremia caused by three anaerobes is rare, D. micraerophilus was detected by PCR and E. clostridioformis and E. lenta was isolated from the drainage pus sample obtained from the pyometra uterus. Therefore, we finally diagnosed the patient with bacteremia caused by D. micraerophilus, E. clostridioformis, and E. lenta associated with pyometra.
P. anaerobius was isolated from the drainage pus sample, although P. anaerobius was not isolated from blood cultures in our case. Incubation of sub-culture plates continued until day 5. Cases of bacteremia caused by P. anaerobius have rarely been reported [27]. P. anaerobius was not detected using BACT/ALERT® FN Plus bottles or BD BACTEC™ Lytic bottles (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) [28] in a previous study. The anticoagulant sodium polyanethol sulfonate inhibits P. anaerobius and was present in both bottle types, possibly explaining why P. anaerobius was not detected [27, 28]. A previous study showed that among 144 anaerobic bacteria isolated from blood cultures, 2.1% (n = 3) were D. pneumosintes. However, P. anaerobius was not detected [24].
The D. micraerophilus isolate in this case was identified by 16S rRNA gene sequencing and MALDI-TOF MS, as previously reported [16]; 16S rRNA gene sequencing [5, 7, 8, 10, 19, 20] and MALDI-TOF MS [6, 21] have also been used to identify D. pneumosintes.
Clinical breakpoints to interpret MICs do not exist for Dialister spp. The D. micraerophilus isolate showed MICs ≤ 0.06–1 µg/mL for β-lactam antimicrobial agents, 4 µg/mL for moxifloxacin, and 16 µg/mL for metronidazole. Although CLSI does not recommend that the broth microdilution method be performed to test for organisms other than Bacteroides spp. and Parabacteroides spp., the MICs for moxifloxacin and metronidazole in the D. micraerophilus isolate were high; moreover, Morio et al. reported a MIC90 of 8 for metronidazole in D. micraerophilus isolates as well as D. pneumosintes isolates [1]. Although antimicrobial susceptibility testing was performed using the Etest method, Cobo et al. reported that the D. micraerophilus isolate showed MICs of 12 µg/mL for metronidazole [16]. Morio et al. reported a MIC90 of 0.25 for moxifloxacin in D. micraerophilus isolates [1], which was lower compared with that of the D. microaerophilus isolated in our case.
In conclusion, we describe a case of a patient with pyometra, with bacteremia caused by D. micraerophilus, C. clostridioforme, and E. lenta. Thus, D. micraerophilus may be associated with gynecological infections. Clinicians should consider not only the oral site but also gynecological sites when searching to identify the focus of D. micraerophilus infection.

Acknowledgements

Not applicable.

Declarations

The study was approved by the Ethical Committee for Epidemiology of Hiroshima University.
Written informed consent was obtained from the patient for publication of this case report.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
18.
Zurück zum Zitat Clinical and Laboratory Standards Institute. M100. Performance standards for antimicrobial susceptibility testing. 33rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2023. Clinical and Laboratory Standards Institute. M100. Performance standards for antimicrobial susceptibility testing. 33rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2023.
Metadaten
Titel
A case of bacteremia caused by Dialister micraerophilus with Enterocloster clostridioformis and Eggerthella lenta in a patient with pyometra
verfasst von
Hiroki Kitagawa
Kayoko Tadera
Keitaro Omori
Toshihito Nomura
Norifumi Shigemoto
Hiroki Ohge
Publikationsdatum
01.12.2024
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2024
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-08999-6

Weitere Artikel der Ausgabe 1/2024

BMC Infectious Diseases 1/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Auf Antibiotika verzichten? Was bei unkomplizierter Zystitis hilft

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO2. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Zeitschrift für Allgemeinmedizin, DEGAM

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.